{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:05:41Z","timestamp":1789646741950,"version":"4.0.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002300","name":"Marsha Rivkin Center for Ovarian Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA195670-S2"],"award-info":[{"award-number":["R01CA195670-S2"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["K99CA234391"],"award-info":[{"award-number":["K99CA234391"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-462168"],"award-info":[{"award-number":["PJT-462168"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.isci.2025.111770","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T19:26:59Z","timestamp":1736278019000},"page":"111770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-4785","authenticated-orcid":false,"given":"Jessica D.","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Selleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Striker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolle A.","family":"Hipschman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle","family":"Kofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2924-1126","authenticated-orcid":false,"given":"Anthony N.","family":"Karnezis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix K.F.","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Rim","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore J.","family":"Facista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.D.","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal A.","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pirrotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6034-007X","authenticated-orcid":false,"given":"Elizabeth A.","family":"Raupach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria L.","family":"Zismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2970-9510","authenticated-orcid":false,"given":"Yemin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Huntsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard E.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Trent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.111770_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ygyno.2016.03.013","article-title":"The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type","volume":"141","author":"Witkowski","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.111770_bib2","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-19-3797","article-title":"Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines","volume":"26","author":"Tischkowitz","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.111770_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2025.111770_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.4633","article-title":"Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type","volume":"238","author":"Karnezis","year":"2016","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.isci.2025.111770_bib5","article-title":"Loss of the tumor suppressor SMARCA4 in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","volume":"2","author":"Ramos","year":"2014","journal-title":"Rare Dis."},{"key":"10.1016\/j.isci.2025.111770_bib6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng.2922","article-title":"Recurrent SMARCA4 mutations in small cell carcinoma of the ovary","volume":"46","author":"Jelinic","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2025.111770_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ng.2928","article-title":"Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4","volume":"46","author":"Ramos","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2025.111770_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ygyno.2017.09.031","article-title":"Comprehensive genomic profiling reveals inactivating SMARCA4 mutations and low tumor mutational burden in small cell carcinoma of the ovary, hypercalcemic-type","volume":"147","author":"Lin","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.111770_bib9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1535-7163.MCT-16-0678","article-title":"Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In\u00a0Vitro and In\u00a0Vivo Preclinical Models","volume":"16","author":"Chan-Penebre","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.isci.2025.111770_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/path.4912","article-title":"The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type","volume":"242","author":"Wang","year":"2017","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.isci.2025.111770_bib11","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1158\/1535-7163.MCT-18-0348","article-title":"Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.isci.2025.111770_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14648","article-title":"The SWI\/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers","volume":"8","author":"Alver","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111770_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/25168657221115656","article-title":"Emerging Themes in Mechanisms of Tumorigenesis by SWI\/SNF Subunit Mutation","volume":"15","author":"Jones","year":"2022","journal-title":"Epigenet. Insights"},{"key":"10.1016\/j.isci.2025.111770_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41588-019-0363-5","article-title":"The ATPase module of mammalian SWI\/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting","volume":"51","author":"Pan","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2025.111770_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng.3746","article-title":"SMARCB1-mediated SWI\/SNF complex function is essential for enhancer regulation","volume":"49","author":"Wang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2025.111770_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","article-title":"Super-Enhancer-Driven Transcriptional Dependencies in Cancer","volume":"3","author":"Sengupta","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.isci.2025.111770_bib17","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-Enhancers in the Control of Cell Identity and Disease","volume":"155","author":"Hnisz","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111770_bib18","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1158\/0008-5472.CAN-18-1545","article-title":"SWI\/SNF-Compromised Cancers Are Susceptible to Bromodomain Inhibitors","volume":"79","author":"Shorstova","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.111770_bib19","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1038\/s41388-018-0300-6","article-title":"ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors","volume":"37","author":"Berns","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2025.111770_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","article-title":"Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes","volume":"153","author":"Whyte","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111770_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Lov\u00e9n","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111770_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2025.111770_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111770_bib24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41467-018-06958-9","article-title":"CDK4\/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111770_bib25","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1158\/1078-0432.CCR-17-1928","article-title":"Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition","volume":"24","author":"Lang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2025.111770_bib26","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2019.01.006","article-title":"p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors","volume":"35","author":"Carugo","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.111770_bib27","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1158\/0008-5472.CAN-18-3066","article-title":"MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors","volume":"79","author":"Howard","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.111770_bib28","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.pan.2015.05.472","article-title":"Minnelide, a novel drug for pancreatic and liver cancer","volume":"15","author":"Banerjee","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.isci.2025.111770_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1412030","article-title":"SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts","volume":"7","author":"Kroemer","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.isci.2025.111770_bib30","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jnci\/djx277","article-title":"Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade","volume":"110","author":"Jelinic","year":"2018","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.isci.2025.111770_bib31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/his.13177","article-title":"Clinical, morphological and immunohistochemical evidence that small-cell carcinoma of the ovary of hypercalcaemic type (SCCOHT) may be a primitive germ-cell neoplasm","volume":"70","author":"McCluggage","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.isci.2025.111770_bib32","doi-asserted-by":"crossref","DOI":"10.1101\/794776","article-title":"Novel functional insights revealed by distinct protein-protein interactions of the residual SWI\/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type","author":"Raupach","year":"2019","journal-title":"Cancer Biol."},{"key":"10.1016\/j.isci.2025.111770_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41389-020-00285-9","article-title":"Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts","volume":"9","author":"Noel","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.isci.2025.111770_bib34","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/genes15101287","article-title":"The Yin and Yang of the Natural Product Triptolide and Its Interactions with XPB, an Essential Protein for Gene Expression and DNA Repair","volume":"15","author":"Gorrie","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.isci.2025.111770_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tips.2019.03.002","article-title":"Triptolide and Its Derivatives as Cancer Therapies","volume":"40","author":"Noel","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2025.111770_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jbmr.5650010309","article-title":"Differential cyclic AMP responses to calcitonin among human ovarian carcinoma cell lines: A calcitonin-responsive line derived from a rare tumor type","volume":"1","author":"Upchurch","year":"1986","journal-title":"J.\u00a0Bone Miner. Res."},{"key":"10.1016\/j.isci.2025.111770_bib37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ygyno.2020.12.004","article-title":"Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines","volume":"160","author":"Karnezis","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2025.111770_bib38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3892\/ijo.2012.1468","article-title":"A tumor-derived population (SCCOHT-1) as cellular model for a small cell ovarian carcinoma of the hypercalcemic type","volume":"41","author":"Otte","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.isci.2025.111770_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/1471-2105-11-237","article-title":"ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data","volume":"11","author":"Zhu","year":"2010","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.isci.2025.111770_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-62703-607-8_8","article-title":"Integrative analysis of ChIP-chip and ChIP-seq dataset","volume":"1067","author":"Zhu","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.111770_bib41","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/gkv1191","article-title":"csaw: a Bioconductor package for differential binding analysis of ChIP-seq data using sliding windows","volume":"44","author":"Lun","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.111770_bib42","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1093\/nar\/gku351","article-title":"De novo detection of differentially bound regions for ChIP-seq data using peaks and windows: controlling error rates correctly","volume":"42","author":"Lun","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.111770_bib43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2025.111770_bib44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12859-017-1708-7","article-title":"Intervene: a tool for intersection and visualization of multiple gene or genomic region sets","volume":"18","author":"Khan","year":"2017","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.isci.2025.111770_bib45","doi-asserted-by":"crossref","first-page":"W160","DOI":"10.1093\/nar\/gkw257","article-title":"deepTools2: a next generation web server for deep-sequencing data analysis","volume":"44","author":"Ram\u00edrez","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.111770_bib46","doi-asserted-by":"crossref","first-page":"D394","DOI":"10.1093\/nar\/gkaa1106","article-title":"PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API","volume":"49","author":"Mi","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.111770_bib47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.111770_bib48","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.isci.2025.111770_bib49","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2025.111770_bib50","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1101\/gr.248658.119","article-title":"Identifying clusters of cis-regulatory elements underpinning TAD structures and lineage-specific regulatory networks","volume":"29","author":"Madani Tonekaboni","year":"2019","journal-title":"Genome Res."},{"key":"10.1016\/j.isci.2025.111770_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.111770_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.111770_bib53","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422500029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422500029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:44:21Z","timestamp":1780087461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258900422500029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S258900422500029X"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.111770","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.08.556863","asserted-by":"object"}]},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.111770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111770"}}